FDA approves 'donanemab' treatment for Alzheimer's disease
The drug contains an antibody that aims to slow the progression of the incurable Alzheimer’s disease. It operates by eliminating the buildup of amyloid protein plaque in the brain.
An illustration of a radiologist analyzing a head CT scan(photo credit: ZEBRA MEDICAL VISION)ByDR. ITAY GALUpdated: